Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

InDx

Financiado

Cerrado

InDx an innovative implant that restores natural motion to patients with thumb...

InDx an innovative implant that restores natural motion to patients with thumb base joint arthritis The thumb base joint is fundamental for human dexterity and functional activity but is prone to debilitating arthritis. Approximately 5% of the world population suffers from this condition with over 25 million Europeans affected.... ver más

31/12/2021

LOCI ORTHOPAEDICS...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

LOCI ORTHOPAEDICS LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 5 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-12-31

EIC-FTI-2018-2020: Fast Track to Innovation (FTI)

I+D

Cerrada hace 7 años

0% 70% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

LOCI ORTHOPAEDICS LIMITED

1.89M€ | Lider

TECNOLOGIA DE CORTE E INGENI...

363.71K€ | Participante

Medvie Limited

293.55K€ | Participante

EndoLab

196.88K€ | Participante

Proyectos interesantes

InDx CMC Implant

Medical Technol...

Biomedical Engi...

4M€ Cerrado

APRICOT

Medical Technol...

Materials Scien...

3M€ Cerrado

HYPORTH

Medical Technol...

Materials Scien...

7M€ Cerrado

Implant Direct

Medical Technol...

Materials Scien...

1M€ Cerrado

DESARROLLO DE UN DISRUPTIVO IMPLANTE ENDOMEDU...

Medical Technol...

Materials Scien...

375K€ Cerrado

BriScrew

Medical Technol...

Materials Scien...

71K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 30 meses Fecha Inicio: 2019-06-24
Fecha Fin: 2021-12-31

Líder del proyecto

LOCI ORTHOPAEDICS LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The thumb base joint is fundamental for human dexterity and functional activity but is prone to debilitating arthritis. Approximately 5% of the world population suffers from this condition with over 25 million Europeans affected. Simple tasks become impossible such as getting dressed, opening a jar, using a key to open a door. This is certainly a relevant socioeconomic and humanitarian concern, which causes a substantial cost burden on healthcare systems, yet the effective treatment for end-stage thumb base arthritis lags far behind other joints, given challenges of the small, complex anatomy. The InDx project aims to enable the commercialization of the InDx implant, the world’s first implant designed to accommodate the complex biomechanics of the thumb base joint and restore the natural movement of the thumb. The consortium is led by Loci Orthopaedics, a technology-driven SME spin-out company from the National University of Ireland, Galway. The partners include EndoLab in Germany, that has developed a novel dynamic test station for implants, NAMSA in the UK, a leading medical research organization with extensive experience in running international clinical investigations, and Medvie, an Irish based SME with extensive project management, dissemination and commercialization expertise. Together, the consortium have brought the implant to TRL 6 level. As part of the InDx project, the consortium will undertake the final stages of product development and will validate clinical results in a clinical study that will prepare the CE marking and market access. Market launch is planned within 24 months from the project start date, following FDA 510K approval in the USA and CE marking in Europe. The consortium estimates cumulative revenues of €51M within 5 years from the start of commercialisation and an employment growth of 25 FTEs for the consortium partners. The InDx has the potential to be a disruptive innovation in the surgical management of thumb base joint arthritis.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores